Viewing Study NCT03745157


Ignite Creation Date: 2025-12-24 @ 6:31 PM
Ignite Modification Date: 2025-12-29 @ 3:34 PM
Study NCT ID: NCT03745157
Status: COMPLETED
Last Update Posted: 2019-12-09
First Post: 2018-11-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: RESILIENT: A Research Study, Looking at How Ryzodeg® Works in People With Type 2 Diabetes in Local Clinical Practice in Japan
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module